record

Riverside Residential - 820 Residential Reintegration

Catskill, NY

Medication used in treatmentDirectory coverage. Read the methodology and limitations.

Facility contact

Care types: Substance use treatment, Transitional housing, halfway house, or sober home Source
Care settings: Residential/24-hour residential, Long-term residential Source
OUD medication support: Medication used in treatment Source
Opioid medications: Buprenorphine used in Treatment Source
Opioid treatment responses: Prescribes buprenorphine, Accepts clients using MAT but prescribed elsewhere Source
Other pharmacotherapies: Acamprosate (Campral®), Buprenorphine sub-dermal implant, Buprenorphine with naloxone, Buprenorphine without naloxone, Buprenorphine (extended-release, injectable) Source
Treatment approaches: Brief intervention, Cognitive behavioral therapy, Motivational interviewing, Relapse prevention, Substance use disorder counseling Source

Payment methods: Federal, or any government funding for substance use treatment programs, Cash or self-payment Source
Payment assistance: Sliding fee scale (fee is based on income and other factors) Source
Telehealth reported: No Source
Transportation assistance: Yes Source
Ancillary services: Residential beds for clients' children, Case management service, Social skills development, Transportation assistance Source

Age groups: Young Adults, Adults, Seniors Source
Special programs: Adult women, Pregnant/postpartum women Source
Co-occurring treatment reported: No Source
All oversight and accreditation responses: State substance use treatment agency Source
Facility operation: Private non-profit organization Source
Directory field completeness: 80 / 100 Source

Research workflow

Unlock shortlist comparison, local notes, export, and complete directory context.